← All organizations
Highest phase reached
Phase 4
First clinical trial
Nov 30, 2009Last known activity
Jan 31, 2026
Timeline
No events for the selected filters.
Drugs by trial phase (17 distinct, 10 trials)
Phase 4 (11 own, 0 via acquisition)
Phase 3 (2 own, 0 via acquisition)
Phase 2 (2 own, 0 via acquisition)
Phase 1 (1 own, 0 via acquisition)
Other trials (1 own, 0 via acquisition)
Indications
Recent trials (11)
- NCT07123363OfficialPhase 1Jan 31, 2026
- NCT07097493OfficialPhase 4Dec 1, 2025
- NCT07053774OfficialPhase 2Nov 5, 2025
- NCT06866964CollaboratorPhase 2May 31, 2025
- NCT06861439OfficialPhase 4May 1, 2025
- NCT06746753OfficialPhase 4Mar 1, 2025
- NCT04678154Overall official - principal investigatorPhase 3May 7, 2021
- NCT01856738CollaboratorPhase 4Nov 1, 2013
- NCT01379898Overall official - principal investigatorPhase 4Dec 1, 2011
- NCT01379898CollaboratorPhase 4Dec 1, 2011
- NCT01139489CollaboratorN/ANov 30, 2009
Details
- Last known activity
- Jan 31, 2026